After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Pliant Therapeutics Inc is $183.17M. A total of 1.79 million shares were traded on the day, compared to an average of 1.43M shares.
In the most recent transaction, Coulie Bernard sold 52,419 shares of PLRX for 11.20 per share on Jan 17 ’25. After the transaction, the President and CEO now owns 430,517 company shares. In a previous transaction on Jan 17 ’25, Cummings Keith Lamont sold 20,148 shares at 11.20 per share. PLRX shares that Chief Financial Officer owns now total 262,608.
Among the insiders who sold shares, Hull Hans disposed of 15,936 shares on Jan 17 ’25 at a per-share price of $11.20. This resulted in the Chief Business Officer holding 211,558 shares of PLRX after the transaction. In another insider transaction, Lefebvre Eric sold 18,478 shares at $11.20 per share on Jan 17 ’25. Company shares held by the Chief Medical Officer now total 194,574.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PLRX has a high of $18.00 and a low of $2.43.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PLRX’s latest balance sheet shows that the firm has $200.60M in Cash & Short Term Investments as of fiscal 2021. There were $7.19M in debt and $16.83M in liabilities at the time. Its Book Value Per Share was $5.68, while its Total Shareholder’s Equity was $199.06M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PLRX is Buy with a score of 3.75.
